
This month's research ethics roundup covers scientists' problems with ClinicalTrials.gov, thoughts from the inventor of CRISPR, the FDA's "Animal Rule," and so-called "parachute science." Read more
This month's research ethics roundup covers scientists' problems with ClinicalTrials.gov, thoughts from the inventor of CRISPR, the FDA's "Animal Rule," and so-called "parachute science." Read more
This edition of Research Ethics Roundup covers overdue trial results and ClinicalTrials.gov, increasing use of hybrid trials, reproducibility issues in cancer studies, and the Smithsonian Tropical Research Institute's #MeToo moment. Read more
This week’s Research Ethics Roundup covers ClinicalTrials.gov reporting, animal researchers scrambling to deal with paused research, funders’ responses to COVID-19, and a novel form of being that challenges the computer-animal barrier. Read more
This edition of Research Ethics Roundup covers ClinicalTrials.gov reporting, the ethics of gene drive technology, varied responses to germline editing, and the insufficiency of deidentification in the protection of subjects in environmental research. Read more
This post draws on information I learned from two presentations. The first, “SBER in the Era of the Revised Common Rule: An Overview of the Most Relevant Regulatory Changes” by Yvonne Lau, MBBS, MBHL, PhD (Director, Division of Education and Development, Office for Human Research Protections), was given at PRIM&R’s 2017 AER conference. The second, “Clinical Trials in the SBER Context” by Melissa W. Riddle, PhD (Chief, Behavioral and Social Sciences Research Branch, National Institute of Dental and Craniofacial Research) and Cindy S. Shindledecker, CIP (Director, Health Sciences and Behavioral Sciences Institutional Review Board, University of Michigan), was given at PRIM&R’s 2017 SBER conference. (Dr. Riddle was absent, but her colleague Wendy Webber, ND, PhD, MPH (Acting Deputy Director, National Center for Complementary and Integrative Health) was able to do an impromptu presentation on behalf of NIH.) Read more